Spago Nanomedical AB SPAGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 0.27
- Day Range
- SEK 0.22–0.27
- 52-Week Range
- SEK 0.20–0.79
- Bid/Ask
- SEK 0.24 / SEK 0.24
- Market Cap
- SEK 54.83 Mil
- Volume/Avg
- 482,962 / 140,712
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 37.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
- Website
- https://www.spagonanomedical.se
Valuation
|
Metric
|
SPAGO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.60 |
Price/Sales | 37.88 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SPAGO
|
|---|---|
Quick Ratio | 5.73 |
Current Ratio | 5.83 |
Interest Coverage | — |
Quick Ratio
SPAGO
Profitability
|
Metric
|
SPAGO
|
|---|---|
Return on Assets (Normalized) | −21.10% |
Return on Equity (Normalized) | −21.78% |
Return on Invested Capital (Normalized) | −22.23% |
Return on Assets
SPAGO
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Bsmhjdyjp | Yynd | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Pjxzvql | Rtctrgk | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Jkzpcyw | Xhxjvr | $108.2 Bil | |
MRNA
| Moderna Inc | Xsltnpvdz | Pccgv | $54.0 Bil | |
ARGX
| argenx SE ADR | Jjckglwc | Xqz | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Gdysqyr | Ctst | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Crnjynvb | Wbrvvql | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Psndhcc | Lnvjpqf | $14.6 Bil | |
INCY
| Incyte Corp | Wdqzfqln | Zrrrrm | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Hswkzmwr | Ynjjpk | $12.3 Bil |